...
首页> 外文期刊>Oncoimmunology. >Tumor infiltration by Tbet plus effector T cells and CD20+B cells is associated with survival in gastric cancer patients
【24h】

Tumor infiltration by Tbet plus effector T cells and CD20+B cells is associated with survival in gastric cancer patients

机译:Tbet加上效应T细胞和CD20 + B细胞的肿瘤浸润与胃癌患者的生存有关

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor-infiltrating T and B lymphocytes could have the potential to affect cancer prognosis. The objective of this study was to investigate the prognostic significance of tumor infiltration by CD8 and CD4 T cells, and B lymphocytes in patients with localized gastric cancer. In a retrospective cohort of 82 patients with localized gastric cancer and treated by surgery we quantitatively assessed by immunohistochemistry on surgical specimen, immune infiltrates of IL-17(+), CD8(+), Foxp3(+), Tbet(+) T cells and CD20(+) B cells both in the tumor core and at the invasive margin via immunohistochemical analyses of surgical specimens. We observed that CD8(+) and IL17(+) T-cell densities were not significantly associated with gastric cancer prognosis. In contrast, high infiltration of Tbet(+) T cells, high numbers of CD20(+) B-cell follicles, and low infiltration of Foxp3(+) T cells, were associated with better relapse-free survival. Interestingly, treatment with neoadjuvant chemotherapy or histological tumor type (diffuse versus intestinal) did not influence type and density of immune infiltrates or their prognostic value. Immunohistochemical analysis of the gastric cancer stromal microenvironment revealed organized T and B cell aggregates, with strong structural analogies to normal secondary lymphoid organs and which could be considered as tertiary lymphoid structures. Using transcriptomic data from an independent cohort of 365 localized gastric cancer, we confirmed that a coordinated Th1, and B cell stromal gene signature is associated with better outcome. Altogether, these data suggest that tumor infiltration by B and Th1 T cells could affect gastric cancer prognosis and may be used to better define the outcome of patients with localized gastric cancer.
机译:肿瘤浸润的T和B淋巴细胞可能会影响癌症的预后。这项研究的目的是调查CD8和CD4 T细胞和B淋巴细胞浸润对局部胃癌患者的预后意义。在82例局限性胃癌患者的回顾性队列研究中,通过手术治疗,我们通过免疫组织化学对手术标本,IL-17(+),CD8(+),Foxp3(+),Tbet(+)T细胞的免疫浸润进行定量评估和CD20(+)B细胞在肿瘤核心和浸润性边缘均通过手术标本的免疫组织化学分析。我们观察到CD8(+)和IL17(+)T细胞密度与胃癌的预后没有显着相关。相反,Tbet(+)T细胞的高浸润,CD20(+)B细胞滤泡的高数目和Foxp3(+)T细胞的低浸润与更好的无复发生存率相关。有趣的是,新辅助化疗或组织学肿瘤类型(弥漫性与肠道性)的治疗不会影响免疫浸润的类型和密度或预后价值。胃癌基质微环境的免疫组织化学分析显示,组织的T细胞和B细胞聚集体与正常的次级淋巴器官具有很强的结构相似性,可以被认为是三级淋巴结构。使用来自365个局限性胃癌的独立队列的转录组数据,我们证实了协调的Th1和B细胞基质基因签名与较好的预后相关。总而言之,这些数据表明,B和Th1 T细胞浸润的肿瘤可影响胃癌的预后,并可用于更好地确定局限性胃癌患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号